Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Cappabianca

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
European Review for Medical and Pharmacological Sciences|September 6, 2022
Total Severity Score (TSS) comparison in vaccinated and unvaccinated patients during the fourth wave (December 2021 - January 2022) of COVID-19 in ItalyG M Russo, M L Mangoni di Santo Stefano, M P Belfiore, et al.
Journal of Endocrinological Investigation|March 30, 2024
Thymic hyperplasia is accurate to detect new-onset Graves' hyperthyroidism and resolves after restoring euthyroidismL Scappaticcio, P Caruso, N Di Martino, et al.
ESMO Gastrointestinal Oncology|April 17, 2026
Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancerV De Falco, P P Vitiello, D Ciardiello, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
European Review for Medical and Pharmacological Sciences|September 6, 2022
Total Severity Score (TSS) comparison in vaccinated and unvaccinated patients during the fourth wave (December 2021 - January 2022) of COVID-19 in ItalyG M Russo, M L Mangoni di Santo Stefano, M P Belfiore, et al.
Journal of Endocrinological Investigation|March 30, 2024
Thymic hyperplasia is accurate to detect new-onset Graves' hyperthyroidism and resolves after restoring euthyroidismL Scappaticcio, P Caruso, N Di Martino, et al.
ESMO Gastrointestinal Oncology|April 17, 2026
Clinical and translational results from the phase II ABACO trial evaluating the activity of cabozantinib in pretreated patients with metastatic colorectal cancerV De Falco, P P Vitiello, D Ciardiello, et al.
Pageof 5